TB drug, Onecure, recalled in Philippines due to ‘insufficient amount of Rifampicin’
by Robert Herriman from Outbreak News Today on (#18GMF)
The Philippines Food and Drug Administration (FDA) announced the recall of the anti-tuberculosis drug, Onecure, after one component of the drug failed specifications. Onecure, which is manufactured by Novartis Ltd. in Tongi, Bangladesh, imported in the Philippines by Sandoz Philippines Corporation and distributed by The Generics Pharmacy Inc., is a combination of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol ["]
